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Background: Excessive use of alcohol is associated with poor sexual health, but the clinical effectiveness
and cost-effectiveness of brief alcohol intervention in this setting has not been investigated.
Objective: To examine the effects and cost-effectiveness of brief intervention for excessive alcohol
consumption among people who attend sexual health clinics.
Design: A two-arm, parallel-group, single-blind, pragmatic, randomised controlled trial. Participants were
randomised via an independent and remote telephone randomisation service using permuted blocks,
stratiﬁed by clinic.
Setting: Study participants were recruited from three sexual health clinics in central and west London.
Participants: For inclusion, potential participants had to be aged ≥19 years, drink excessive alcohol
according to the Modiﬁed-Single Alcohol Screening Question, and be willing to provide written informed
consent. We excluded those who were unable to communicate in English sufﬁciently well to complete the
baseline assessment and those who could not provide contact details for the follow-up assessment.
Interventions: Brief advice was delivered by the treating clinician and comprised feedback on the
possible health consequences of excessive drinking, a discussion of whether the participant’s clinic
attendance was linked to current alcohol use, written information on alcohol and health and an offer of
an appointment with an alcohol health worker (AHW). Appointments with AHWs took place either in
person or by telephone, lasted up to 30 minutes, and used the ‘FRAMES’ (Feedback about the adverse
effects of alcohol, an emphasis on personal Responsibility for changing drinking behaviour, Advice about
alcohol consumption, a Menu of options for further help and advice, an Empathic stance towards the
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patient and an emphasis on Self-efﬁcacy) approach. Those in the control arm of the trial were offered
a copy of a leaﬂet providing general information on health and lifestyle.
Main outcome measures: Outcomes were assessed 6 months after randomisation. The primary outcome
was mean weekly alcohol consumption during the previous 90 days. The main secondary outcome was
unprotected sex during this period.
Results: Eight hundred and two people were recruited to the study of whom 592 (74%) were followed up
6 months later. Among 402 participants who were randomised to brief intervention, 397 (99%) received
brief advice from the treating clinician and 81 (20%) also received input from an AHW. The adjusted
mean difference in alcohol consumption after 6 months was –2.33 units per week [95% conﬁdence interval
(CI) –4.69 to 0.03 units per week, p = 0.053] for those in the active arm compared with the control arm.
Unprotected sex was reported by 154 (53%) of those who received brief intervention and by 178 (59%) of
controls (adjusted odds ratio 0.89, 95% CI 0.63 to 1.25, p = 0.496). Participants randomised to brief
intervention reported drinking a mean of 10.4 units of alcohol per drinking day compared with 9.3 units
among control participants (difference 1.10, 95% CI 0.29 to 1.96, p = 0.009). We found no statistically
signiﬁcant differences in other outcomes. Brief intervention (brief advice and input from an AHW) cost on
average £12.60 per person to deliver and did not appear to provide a cost-effective use of resources.
Conclusions: Introduction of universal screening and brief intervention for excessive alcohol use among
people who attend sexual health clinics does not result in clinically important reductions in alcohol
consumption or provide a cost-effective use of resources. While people attending sexual health clinics may
want to achieve better sexual health, attempts to reduce alcohol consumption may not be seen by them as
a necessary means of trying to achieve this aim.
Trial registration: This trial is registered as ISRCTN 99963322.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment; Vol. 18, No. 30. See the NIHR Journals Library website
for further project information.
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Plain English summary
Many people who attend sexual health clinics drink more than the recommended amount of alcohol.We therefore set out to examine whether or not giving advice about alcohol and health to people
who attend these clinics and drink excessively helped them drink less and achieve better sexual health, and
whether or not the provision of such advice provided good value for money.
We conducted the study in three sexual health clinics in London. We gave half of the people attending
these clinics who were drinking above recommended levels of alcohol a leaﬂet on health and lifestyle.
The other half was offered brief intervention. This consisted of brief advice, a leaﬂet on alcohol and health,
and the offer of an appointment with an alcohol health worker (AHW) who could provide further
information and support. We collected follow-up information from people 6 months after they entered
the study.
At follow-up, we found little difference in the amount that people who had been offered brief intervention
were drinking. People offered the intervention drank just over 2 units of alcohol – about one pint of
lager – less per week. We did not ﬁnd differences in sexual health between those who were offered brief
intervention and those who were not.
Many people who attend sexual health clinics are drinking at above recommended levels but the type of
intervention we examined did not lead to big differences in the amount they drank. Offering this type
of intervention to people who attend sexual health clinics and drink excessively does not provide a good
use of resources.
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Scientiﬁc summary
Background
Concerns have been expressed about high levels of alcohol consumption among people attending sexual
health clinics. Cross-sectional surveys have repeatedly demonstrated that a high proportion of people
attending these clinics are drinking above recommended levels. It has been reported that those who drink
excessively are more likely to be diagnosed with a sexually transmitted infection (STI). Brief intervention for
excessive alcohol consumption has been shown to be effective across a range of medical settings, but
there is very little evidence about its impact when offered to people attending sexual health clinics. The
effects of brief intervention for excessive alcohol consumption on sexual health outcomes have not been
examined and cost-effectiveness of this approach is unknown.
Objectives
We aimed to examine the clinical effectiveness and cost-effectiveness of opportunistic brief intervention for
excessive alcohol use among people who attend sexual health clinics. To achieve this aim we:
l examined whether or not brief intervention reduced subsequent alcohol consumption measured
6 months later compared with control treatment
l examined whether or not brief intervention compared with control treatment was associated with
changes in sexual behaviour
l examined the cost-effectiveness of brief intervention compared with control treatment.
Methods
Study design
The study was a single-blind, parallel-group, randomised controlled trial.
Participants
Study participants were recruited from three sexual health clinics in central and west London. To take part
in the study, potential participants had to be aged 19 years or above, be drinking excessively according
to the Modiﬁed-Single Alcohol Screening Question and be willing to provide written informed consent.
We excluded any person who was unable to communicate in English sufﬁciently well to complete baseline
questionnaires, anyone who did not have an address or contact telephone number and anyone who
believed they may not have been contactable again 6 months later.
Main outcome measures
All outcomes were measured 6 months after randomisation and assessed behaviour in the 3 months prior
to the date of the assessment. The primary outcome was mean weekly alcohol consumption (measured
using the Form 90) and the main secondary outcome was the proportion of participants who reported any
unprotected sex during the previous 3 months. Secondary outcomes were mean units of alcohol
consumed per drinking day and percentage days abstinent (both measured using the Form 90); whether or
not the participant was drinking excessively; total number of sexual partners; number of unprotected
sexual partners; any incidence of regretted sex; any incidence of unprotected sex after drinking alcohol or
while drunk; how long they knew their last sexual partner before they had sex with them; unplanned
pregnancy; and any new diagnosis of a STI. Finally we collected data on health-related quality of life
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(measured using the European Quality of Life-5 Dimensions scale), and resource use during the past
6 months measured using a modiﬁed version of the Adult Service Use Schedule.
Study procedures
On days when recruitment took place, clinic staff gave all those attending the service a postcard with
information about the study and asked people whether or not they would be willing to meet a researcher.
If they agreed, the researcher met with them and provided information about the study. If the
participant provided written informed consent, the researcher assessed eligibility and collected baseline
data. Baseline assessments were completed using a computer-assisted self-completion questionnaire.
Following completion of baseline assessments, participants were randomised via an independent and
remote telephone randomisation service by an independent Clinical Trials Unit using permuted blocks,
stratiﬁed by site. Block size was randomly assigned between four and six. Equal numbers of participants
were randomised to each arm of the trial. The researcher then notiﬁed the treating clinician which arm of
the trial the participant was in.
The Sexual Health and Excessive Alcohol: Randomised trial (SHEAR) had two treatment conditions.
Brief intervention comprised brief advice delivered by the treating clinician followed by input from an
alcohol health worker (AHW) for those willing to receive it. Those randomised to control treatment
received a general health information leaﬂet with advice about smoking, alcohol, diet and exercise.
Brief advice from the treating clinician consisted of feedback on the possible health consequences of
excessive alcohol consumption, written information about alcohol and health, and an offer of an
appointment with an AHW. The appointment with the AHW lasted up to 30 minutes. In the case of any
participant who was drinking at a harmful or dependent level, the AHW had the option of arranging a
follow-up appointment or referring the participant to local alcohol services for individual alcohol
counselling, detoxiﬁcation or other treatments. Any participant who was unable to attend an appointment
on the day was offered an appointment at a later date or the option of telephone-based information
and advice.
After 6 months the participants were contacted by a researcher masked to the participant allocation status
and asked to complete a telephone interview. Participants who completed the follow-up interview were
offered a £15 honorarium in recognition of their time and any inconvenience related to their involvement
in the study.
Statistical methods
The initial sample size calculation was based on identifying differences in mean weekly alcohol
consumption found in our previous trial of brief intervention in an emergency department. In the ﬁrst few
months of the trial the rate of recruitment was higher than expected and the sample size was therefore
increased to provide additional power to test both the primary and main secondary outcome: the
proportion reporting unprotected sexual intercourse during the previous 3 months.
The ﬁnal sample size was based on a practical size of 380 per arm (760 in total). If 65% of participants
had unprotected sex in the control group compared with 50% in the intervention arm, the power to
detect such an effect would be above 90%, assuming 25% drop-out, and a clustering design effect
of 1.15.
Results
Eight hundred and two participants were recruited to the trial between August 2010 and May 2012, of
whom 402 were randomised to brief intervention and 400 to control treatment. Participants had a median
age of 27 years (interquartile range 24–30 years) and 432 (54%) were female. All but ﬁve participants in
the active arm of the trial received brief advice from the treating clinician (n = 397, 99%). Of these,
81 participants (20%) also received input from an AHW.
SCIENTIFIC SUMMARY
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Two hundred and ninety-one participants (72%) in the intervention arm and 301 participants (75%) in the
control arm completed the follow-up interview. The participants allocated to the intervention arm were
drinking 18.1 units per week and those allocated to the control arm were drinking 20.3 units per week.
The adjusted mean difference in alcohol consumption between those in the active arm of the trial and
those in the control group was therefore –2.33 units per week [95% conﬁdence interval (CI) –4.69 to
0.03 units per week, p = 0.053]. Unprotected sex was reported by 154 (53%) of those randomised to brief
intervention and by 178 (59%) of those randomised to the control treatment (adjusted odds ratio 0.89,
95% CI 0.63 to 1.25, p = 0.496). Participants randomised to brief intervention reported drinking a mean
of 10.4 units of alcohol per drinking day compared with 9.3 units among the control group (a difference
of 1.1 units, 95% CI 0.29 to 1.96 units, p = 0.009). We did not ﬁnd signiﬁcant differences in any other
secondary outcomes between each arm of the trial.
Mean costs per participant over 6 months were £319 among those randomised to brief intervention and
£311 among those randomised to the control treatment. Although the additional cost of brief intervention
was small compared with the total cost of care provided (£12.57, standard deviation £6.59), we did not
ﬁnd evidence to support the cost-effective use of this intervention.
Conclusions
We did not ﬁnd evidence that brief intervention for excessive alcohol use among people attending
sexual health clinics is associated with clinically important reductions in alcohol consumption or provides a
cost-effective use of resources.
Recommendations for future research
1. Interventions for young people who present to sexual health services and drink at a level that may be
harmful to their health should be developed and tested.
2. The impact that population-based strategies for reducing levels of alcohol misuse have on sexual
health outcomes should be examined as part of wider efforts to assess their impact on
health-related outcomes.
Trial registration
This trial is registered as ISRCTN 99963322.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Aims
The Sexual Health and Excessive Alcohol: Randomised trial (SHEAR) aimed to examine the effects andcost-effectiveness of opportunistic brief intervention for alcohol misuse among people who attend
sexual health clinics and are found to consume excessive alcohol. To achieve this aim we:
1. tested whether or not brief intervention reduced subsequent alcohol consumption measured 6 months
later compared with control treatment
2. examined whether or not brief intervention compared with control treatment was associated with
changes in sexual behaviour
3. examined the cost-effectiveness of brief intervention compared with control treatment.
Hypotheses
i. Brief intervention for those attending sexual health clinics and drinking excessively reduces
mean weekly alcohol consumption over a 12-week period prior to the 6-month follow-up interview
(i.e. weeks 13–24 after intervention).
ii. Brief intervention for those attending sexual health clinics and drinking excessively reduces the
likelihood of unprotected sexual intercourse over a 12-week period prior to the 6-month
follow-up interview.
iii. Brief intervention for those attending sexual health clinics and drinking excessively is more cost-effective
than control treatment.
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Chapter 2 Background
Concerns have been raised regarding increases in levels of alcohol consumption in many countries.1It is estimated that as many as one in ﬁve adults in the UK drinks too much alcohol.2 This may take
the form of sustained excessive consumption or episodic bouts of ‘binge’ drinking. Excessive alcohol
consumption can lead to a range of physical and mental health problems which are estimated to result in
direct costs to the NHS of £3B a year.3
Increasing levels of alcohol misuse in the UK have been accompanied by large increases in rates of sexually
transmitted infections (STIs).4 Data from observational studies show that alcohol consumption and sexual
ill health may be linked. Bellis and colleagues found among a large sample of young people in nine
European cities that alcohol consumption was associated with number of sexual partners and age at ﬁrst
sexual contact.5 In the USA, changes in the price of alcohol in the 1980s and 1990s were highly correlated
with changes in rates of gonorrhoea,6 and policies which succeeded in reducing drunk driving rates in
young men in the USA were noted to be associated with reductions in gonorrhoea rates among young
males.7 A meta-analysis of data from a range of observational studies concluded that excessive alcohol use
is associated with increased likelihood of STIs.8
A number of cross-sectional studies among people attending sexual health clinics have demonstrated high
levels of alcohol consumption. We found that one-third of people attending a sexual health clinic in
London were drinking excessively,9 and others have reported even higher levels.10 Among teenagers,
levels are higher still, with up to 70% drinking excessively.11 In a pilot study which involved collecting
cross-sectional data from 253 patients attending a sexual health clinic in central London, we found that
40% of people who drank excessively believed their attendance was related to alcohol.
Within the NHS, interventions for individuals who drink excessively include those delivered to people who
request help with their drinking and those who are found to be drinking excessively when they present to
health-care services for other reasons. These ‘opportunistic’ interventions involve assessment of alcohol
use followed by information, advice and techniques aimed at promoting behavioural change. Research
conducted in other contexts has demonstrated the value of brief interventions for excessive drinking.12,13
Systematic reviews of brief interventions for excessive alcohol use have shown that interventions delivered
in one session appear to be as effective as more lengthy ones.14,15 More recently, ‘stepped interventions,’
in which people receive interventions of greater intensity depending on the extent of their needs, have
also demonstrated positive effects.16 Those with excessive use of alcohol are offered brief feedback and
information and the offer of additional treatment, and those with harmful or dependent alcohol misuse
are offered referral on to other services, if required.
The content of brief interventions for alcohol misuse varies but generally includes features incorporated
in the acronym FRAMES (Feedback about the adverse effects of alcohol, an emphasis on personal
Responsibility for changing drinking behaviour, Advice about alcohol consumption, a Menu of options for
further help and advice, an Empathic stance towards the patient and an emphasis on Self-efﬁcacy).17,18
In addition to reducing levels of alcohol consumption, brief interventions have also been shown to lead
to reductions in accidents and injuries and reattendance to hospital.16,19,20
Although many studies have drawn attention to associations between alcohol misuse and poor sexual
health, very few studies have examined the acceptability or impact of opportunistic intervention for alcohol
use among people attending sexual health clinics. We have previously reported that most people who
attend sexual health clinics and are found to be drinking excessively are willing to receive brief advice.9 In
their study of young people aged 14–17 years who attended a sexual health clinic in Glasgow, UK, and
were found to be drinking excessively, Keogh and colleagues reported that 68% accepted the offer of
brief intervention and two-thirds of these received it.11 The only randomised trial of brief intervention for
alcohol in a sexual health setting to have been published to date was conducted by Lane and colleagues in
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a single clinic in Sydney, Australia.21 Among 133 people who took part in the study and completed
a 3-month follow-up interview, there was a non-statistically signiﬁcant trend towards lower levels of
excessive drinking among those in the active arm of the trial.
Recognition of the link between alcohol misuse and poor sexual health led to the Royal College of
Physicians to call for research examining the impact of interventions to reduce alcohol misuse on sexual
behaviour.22 However, to date, no study has been large enough to demonstrate clinically important
reductions in alcohol use among people attending sexual health clinics or examined the impact of this
intervention on sexual behaviour.
BACKGROUND
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Chapter 3 Methods
The study was a parallel-arm, single-blind, individually randomised controlled trial exploring the clinicaleffectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among
adults aged ≥19 years who attend sexual health clinics. The trial was an integrated clinical and economic
evaluation and compared the effects of brief intervention with the effects of control treatment on
excessive alcohol consumption, sexual behaviour, health-related quality of life and costs in the 6 months
after randomisation.
Ethical approval was obtained from West London Research Ethics Committee 3 (10/H0706/29) and the
study protocol was registered with Controlled Clinical Trials (ISRCTN 99963322) prior to the start of
data collection.
Changes to original protocol
Prior to the start of the study, but following trial registration, one of the clinics where we were due to
recruit participants withdrew from the study as it was unable to provide input from an alcohol health
worker (AHW). Recruitment was therefore restricted to three sites. Another clinic started to provide
additional support for young people aged ≤18 years aimed at promoting sexual health. This intervention
included discussion of alcohol use. We therefore changed our eligibility criteria to include only those
aged ≥19 years.
We made one additional change to the study after commencement. The original sample size for the study
was set at 320, which was judged to be large enough to detect clinically important differences in levels of
alcohol consumption among those offered active and control treatment. In the ﬁrst few months of the trial
it became clear that the rate of recruitment was higher than we had originally anticipated. With the
support of the funder and the independent Trial Steering Committee and following approval of the
Research Ethics Committee we increased the sample size to 760 in order to have sufﬁcient power to
examine clinically important differences in our main secondary outcome: the proportion of participants
who reported any unprotected sex at follow-up.
The public and patients were involved at several stages of the study (see Appendix 1 for further details).
Study setting and sample
Study participants were recruited from three sexual health clinics in central and west London. These
clinics serve a diverse population of over 500,000 people with high levels of alcohol misuse and poor
sexual health.22,23
To participate in the study people had to be aged ≥19 years, be drinking excessively according to the
Modiﬁed-Single Alcohol Screening Question (M-SASQ)24 and be willing to provide written informed
consent to take part in the study. We excluded any person who was unable to communicate in English
sufﬁciently well to complete baseline questionnaires, anyone who did not have an address or contact
telephone number and anyone who believed they may not have been contactable in 6 months’ time.
Study interventions
The SHEAR had two treatment conditions: brief intervention for excessive use of alcohol and
control treatment.
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Brief intervention
Brief intervention was based on that used in a previous trial conducted in an emergency department16 and
was found previously to be acceptable to clinicians in a sexual health clinic.9 The intervention is designed
to be used by busy front-line clinicians such that it can be delivered within 2 or 3 minutes. The intervention
is designed to deliver the treating clinician after they have dealt with the person’s presenting complaint.
The intervention consists of four components:
i. conﬁrming the current level of alcohol use and brief feedback that alcohol use at that level has the
potential to harm health
ii. making a link between alcohol and clinic attendance
iii. written information on alcohol and health in the form of a leaﬂet recommended by the Department of
Health: ‘How much is too much?’25
iv. the offer of an appointment with an AHW.
This form of brief advice is shorter than some other forms of intervention, which can take 5–10 minutes to
deliver. It is focused on these four simple tasks. Verbatim text that can be used to deliver each of these is
available at: www.alcohollearningcentre.org.uk/_library/PAT_2011_Paddington_Alcohol_Test.pdf.
On days when participants were recruited from the clinics, an AHW was available to see those who were
willing to receive further help. The appointment with the AHW lasted up to 30 minutes and used the
FRAMES approach.17,18 In the case of any participant who was drinking at a harmful or dependent level,
the AHW had the option of arranging a follow-up appointment or referring the participant to local alcohol
services for individual alcohol counselling and other services. In the event that the participant was unable
to attend an appointment that day, he or she was offered an appointment at a later date or
telephone-based support and advice.
Control treatment
Those randomised to control treatment were offered a copy of the leaﬂet ‘Five Choices to Help You Stay
Healthy’.26 This provides general information on health and prevention of ill health including information
on alcohol use, diet, exercise and cigarette smoking and details of how to obtain further information
about health and lifestyle.
Training and support for the delivery of brief intervention
A short training session was delivered at each of the hospital sites before participants were recruited. This
session was incorporated into existing staff meetings. In the session, we provided background to the study,
an overview of study logistics and details of each of the four components of the brief advice that clinicians
were asked to provide those in the active arm of the trial. Clinicians were asked to use recommended text
for delivering each of the four components of the intervention and encouraged to use web-based
information at www.alcohollearningcentre.org.uk.27
In addition to this, the lead researcher (RS) spoke to front-line clinicians on the days when recruitment was
taking place. She provided support and advice to clinicians, gave feedback on their performance and
checked that brief advice was being delivered in accordance with the trial protocol.
All AHWs who took part in the study were experienced practitioners who had undertaken speciﬁc training
in counselling people who misuse alcohol. Three were employed by the NHS and one was employed by a
statutory organisation (Turning Point). All AHWs received regular clinical supervision. AHWs were
encouraged to discuss work with trial participants along with other patients they saw during
these sessions.
METHODS
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Treatment ﬁdelity
In order to assess treatment ﬁdelity, clinicians delivering brief advice and AHWs were asked to complete a
treatment proforma for each person they saw. These proforma can be found in Appendices 2 and 3 of this
report. The proforma completed by clinicians was based on one we used in a previous trial.16 Front-line
clinicians were asked to indicate whether or not they had delivered each of the four components of brief
advice and AHWs were asked to complete a longer proforma which recorded the number and length of
session(s), interventions delivered during the session(s) and further information of referrals that were
subsequently made. A member of the research team was on hand to check completion of these proforma
and to support and advise clinicians on delivering brief advice if required. Proforma were examined at the
end of the study to identify the proportion of those in the active arm of the trial who received brief advice
and brief intervention.
Outcome measures
Primary and secondary outcomes
The primary outcome was mean weekly units of alcohol consumed during the previous 90 days. The main
sexual health outcome of interest was having had any unprotected vaginal or anal sex in the past 3 months;
this was referred to as our ‘main secondary outcome’. Both of these variables were measured at follow-up.
The other secondary outcomes are detailed below in the report.
Baseline
Basic demographic and clinical data on age (years), gender, ethnicity and reason for presentation were
extracted from clinic records at baseline and checked with the participants.
Alcohol consumption was assessed using the M-SASQ. The M-SASQ is a brief validated measure of
excessive alcohol use that is acceptable to patients in general medical settings.24 It consists of a single
question – for men: ‘How often do you drink more than 8 units of alcohol on one occasion?’ and for
women: ‘How often do you drink more than 6 units of alcohol on one occasion?’ To help people answer
this question they are shown a card which describes what 1 unit of alcohol is. Those drinking this amount
once a month or more were considered eligible to participate in the trial. The question on alcohol was
embedded in a series of four other questions asking about diet, exercise and smoking. In addition, eligible
participants were asked about:
i. Sexual behaviour during the last 3 months using key variables that have been validated in other
studies.28 The variables comprised: number of sexual partners; number of people with whom they had
unprotected sex with (vaginal or anal sex without a condom); any incidence of regretted sex; and how
long they had known their last sexual partner before they had sex with them.
ii. Health-related quality of life using the European Quality of Life-5 Dimensions (EQ-5D).29 This is a generic
preference-based measure for describing and valuing health-related quality of life assessed in ﬁve
domains (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Utility scores are then
derived from the EQ-5D, with higher scores indicating a better quality of life.
Six-month follow-up
Follow-up data were obtained by a telephone interview carried out by a researcher who was masked to
the participant’s allocation status. The following outcomes were examined:
i. Alcohol consumption in the last 90 days using the Form 90. The Form 90 is a validated alcohol
consumption assessment tool which provides a detailed day-by-day account of alcohol use in
the 90 days prior to the interview.30 Data from this questionnaire were used to calculate the
primary outcome – mean weekly units of alcohol consumed during the previous 90 days.
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Secondary alcohol-related outcomes were mean units consumed per drinking day, percentage of days
abstinent and whether the participant was drinking excessively according to the M-SASQ criteria.
ii. Sexual behaviour in the last 90 days was assessed by a set of questions including total number of
sexual partners; number of partners with whom the participant had had unprotected sex; any incidence
of regretted sex; any incidence of unprotected sex after drinking alcohol and while feeling drunk; how
long participants knew their last sexual partner before they ﬁrst had sex with them; unplanned
pregnancy; and any new diagnosis of a STI.
iii. Service use data for the economic evaluation were collected using the Adult Service Use Schedule
(AD-SUS), an interviewer-assessed instrument designed by one of the authors and based on previous
economic evaluations in similar adult mental health and addiction populations.31 The AD-SUS records
the number and duration of contacts with a range of health and social service professionals, all hospital
contacts and medications taken. Data on uptake of the brief intervention were collected from records
to avoid participants revealing their treatment group to the research assessors. Data on indirect time,
including preparation and supervision, were collected directly from the treating clinician.
Study procedures
Recruitment
At each clinic where recruitment took place we displayed posters in the waiting room providing
information about the study. On days when recruitment took place, clinic staff gave all those attending the
service a postcard with information about the study and asked people whether or not they would be
willing to meet a researcher. If they agreed, the researcher explained the rationale for the study and gave
the person a copy of the patient information leaﬂet. The researcher encouraged potential participants to
spend as much time as they wanted asking questions about the study and considering whether or not
they wish to take part. Average waiting times in these clinics between presenting to reception and seeing
a clinic doctor are over 2 hours. This ensured that potential participants had sufﬁcient time to hear about
the study, consider whether or not they wanted to participate and complete the baseline assessment. Prior
to completing the baseline assessment, participants signed and dated the informed consent form. For
those willing to provide consent, eligibility to participate in the study was assessed and baseline clinical
and demographic data were collected. Baseline assessments were completed using a computer-assisted
self-completion interview.32,33
Contact details were then sought to enable the researchers to contact the participant at follow-up.
Researchers were assisted in recruitment by clinical studies ofﬁcers of the UK Mental Health
Research Network.
The researcher provided all those who were ineligible with written information about health and lifestyle
if they wanted this.
Randomisation
Participants were randomised via an independent remote automated telephone-based service operated by
the Clinical Trials Unit at the University of Aberdeen, UK. Permuted blocks stratiﬁed by the clinic were
used, with allocation ratio between arms of 1 : 1 and block sizes randomly assigned to four or six.
The researcher notiﬁed the treating clinician as to which arm of the trial the participant was in. All other
members of the trial team, including researchers involved in the collection of follow-up data, were masked
to treatment allocation.
METHODS
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Follow-up
Three months after randomisation, study participants received a telephone call, text or e-mail, thanking
them for taking part in the study and reminding them that they would be contacted in 3 months’ time to
complete the follow-up interview. They were also asked whether or not their contact details were likely to
change during this period. If, at 6 months, our attempts to contact a participant were unsuccessful, and
consent had been given, the researchers checked the participant’s contact details against those given
during any subsequent visits to the clinic and contacted a nominated family member or friend. Follow-up
interviews were carried out by telephone.
Masking of raters
Data were held securely and were password protected. Details of allocation status were held separately
and were not accessible to the researchers involved in collecting follow-up data. Researchers involved in
recruiting study participants played no part in follow-up interviews. Information on receipt of brief advice
and brief interventions was gathered separately from proforma completed by clinicians and AHWs.
Participant honoraria
Participants who completed the follow-up interview were offered a gift voucher for £15 in recognition of
their help with the study and to compensate them for any inconvenience they experienced.
Sample size
In the absence of information on weekly alcohol consumption among people attending sexual health
clinics we based our sample size calculation on data from a previous trial set in an emergency
department.16 We calculated that 97 evaluable participants would be needed per treatment arm to have
80% power to detect a difference in mean weekly alcohol consumption of 23.4 units with a standard
deviation (SD) of 58.0 units (or 0.40 standardised difference), using a 5% level of statistical signiﬁcance.
However, a clustering effect may occur in the intervention arm due to different clinicians delivering the
intervention. Power calculation formulae for a partially clustered design have been reported by Roberts and
Roberts.34 Based on an average cluster size of 7 and an intraclass correlation coefﬁcient of 0.04 in the
intervention arm, a total of 112 evaluable patients in each arm (16 clusters of 7 in the control group)
would provide above 80% power to detect such a difference. This corresponds to an inﬂation factor for
clustering (design effect) of 1.15. Expecting a 30% drop-out rate at 6 months, we therefore aimed to
recruit 320 participants.
During the ﬁrst few months of the trial it became clear that the rate of recruitment was higher than we
anticipated; the sample size was therefore modiﬁed to provide additional power to test both the primary
and main secondary hypotheses (a reduction in unprotected sexual intercourse).
The ﬁnal sample size was based on a practical size of 380 per arm (760 in total). If 65% of participants
had unprotected sex in the control group, compared with 50% in the intervention arm, the power to
detect such an effect would be above 90%, assuming 25% drop out, and a clustering design effect of
1.15. The power would remain above 80% if the absolute difference was above 13%.
Statistical analysis
A detailed statistical analysis plan was developed and published online before analysis.35 We used the
statistical package Stata (StataCorp LP, College Station, TX, USA; version 12) for all of the descriptive
analysis, graphs and regression models. All analyses were carried out according to randomisation arm
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(intention to treat), and two-sided p-values were considered signiﬁcant when < 0.05. Descriptive analyses,
including tables and graphs of baseline demographic and clinical variables, were conducted.
The primary outcome was compared between arms using random-effects linear regression adjusted
for age (years), sex, clinic and M-SASQ measured at baseline. A random effect was included in the
intervention arm to take into account any possible clustering by the clinician delivering the intervention,
and residuals were allowed to differ by arm. This corresponds to the analysis suggested for partially nested
trial design by Walwyn and Roberts.36 Sensitivity analyses were then performed to conﬁrm the validity of
the result. Different hierarchical models were ﬁtted and standard errors were calculated using approaches
more robust to non-normally distributed residuals, such as robust standard errors or non-parametric
bootstrapping. Ten thousand bootstrap resamples were obtained to achieve stable estimates. Results
of direct mean comparison (t-test) and of adjustment for imbalanced baseline characteristics were
also explored.
The main secondary outcome was analysed using random-effects logistic regression and adjusting for
unprotected sex at baseline. As for the primary outcome, various sensitivity analyses were also performed.
Other secondary outcomes were compared using appropriate regressions or tests and adjusted for age
(years), sex, clinic and the corresponding outcome variable at baseline. As the addition of a clinician
random effect was found to have little effect on results, it was ignored for the comparison of
secondary outcomes.
Baseline data were missing for one participant, and mean imputation was used in this case for adjusted
analyses.37 Baseline characteristics of participants who dropped out from the trial were compared with the
completers. Multiple imputation by chained equations was performed to impute the primary and main
secondary outcomes at the follow-up visit. The imputation model included the important predictors of
missingness and outcomes. Predictive mean matching was used to impute the alcohol consumption.
Imputation was performed stratiﬁed by randomisation arm, and clustering by clinician was ignored in the
imputation and analysis model. In order to reach negligible Monte Carlo error, 500 imputations were
performed. Further sensitivity models allowing for missing not-at-random mechanism were also
considered.38 They were based on a pattern mixture approach, considering a large range of possible
differences in outcomes between participants who completed the follow-up and those who did not.
Mean difference and conﬁdence intervals (CIs) were estimated using the ‘rctmiss’39 user-written command
in Stata.
To assess for possible heterogeneity of the intervention effect, primary and main secondary outcomes are
also reported by the following subgroups: gender, age (< 25 years, 25–35 years, > 35 years), number of
sexual partners in the 6 months preceding baseline (1 vs. > 1), and sexual orientation (heterosexual vs.
non-heterosexual). We then tested for the presence of an interaction term between the subgroups and
treatment arm. Age (years) was additionally tested as a continuous variable and considered to have a linear
effect in the regression. For participants in the intervention arm, the alcohol consumption was also
described by categories of intervention received.
Economic analysis
Estimation of costs
The economic evaluation took a NHS/Personal Social Service perspective, as recommended by the National
Institute for Health and Care Excellence (NICE),40 and included all hospital contacts (inpatient, outpatient,
accident and emergency), community health and social services (primary health care, community health
services and social services) and medication.
All unit costs were for the ﬁnancial year 2010–11. A summary of unit costs applied is listed in Table 1.
Costs for NHS hospital contacts were sourced from NHS reference costs 201141 and community health and
METHODS
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social service costs were taken from the annual unit costs of health and social care publication from the
University of Kent42 or from relevant websites (as outlined in Table 1). The cost of medications were
calculated based on averages for British National Formulary chapters and were taken from Prescription
Cost Analysis.44
The cost of the intervention was estimated using the micro-costing (bottom-up) approach set out by the
Personal Social Services Research Unit at the University of Kent, UK.42 We assumed that the brief advice
was delivered by registrars, so used the median salary for registrars as the starting point. To this, employer
national insurance and pension contributions were added as well as direct and indirect overhead costs to
reﬂect hospital costs, administrative and managerial support costs, and capital costs. Total salary and
overhead costs were then divided by the number of working hours per year, taken from Curtis,42 to
calculate the cost per hour. Adjustments to this cost were made to reﬂect time taken by physicians in
direct contact with patients and time spent on other activities. If the study participant saw an AHW in
addition to the treating clinician then the cost of the AHW was added separately and reported as part of
the cost of the intervention. The costs of the training were not included in the cost of the intervention.
Calculation of quality-adjusted life-years
Quality-adjusted life-years (QALYs) were calculated on the basis of the EQ-5D health state classiﬁcation
instrument, where health states are assigned a utility score using responses from a representative sample
of adults in the UK.45 QALYs were calculated as the area under the curve deﬁned by the utility values at
baseline and 6-month follow-up and it was assumed that changes in utility score over time followed a
linear path.46 An individual with perfect health would have an EQ-5D score of 1, which would translate to
a QALY estimate of 0.5 QALYs over the 6-month follow-up.
TABLE 1 Unit costs and sources used in economic evaluation
Variable Unit cost or range (£) Source
Inpatient (per night) 415.00–550.00 NHS reference costs41
Outpatient (per appointment) 29.00–1178.00 NHS reference costs41
Accident and emergency (per attendance) 130.00 NHS reference costs41
GP (per minute) 1.10–2.10 Curtis 201142
Practice nurse (per minute) 0.72 Curtis 201142
Health visitor/district nurse (per visit) 46.00 NHS reference costs41
Physiotherapist (per contact) 47.00 NHS reference costs41
Counsellor (per minute) 1.10 Curtis 201142
Chiropody/podiatry (per contact) 47.00 NHS reference costs41
Advice centre (per minute) 0.45 Curtis 201142
Complementary medicine (per contact) 60.00 Web search February 2013
NHS Direct (per call) 15.64 www.nhsdirect.nhs.uk43
Community sexual health clinic (per contact) 65.00 NHS reference costs41
GP, general practitioner.
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Cost-effectiveness analysis
Differences in use of services between randomised groups at the 6-month follow-up are
reported descriptively.
Differences in mean cost per participant were tested between groups using the Student’s t-test with
ordinary least squares regression, and bootstrapping to conﬁrm the validity of the results.47 Standard
statistical tests were used because of the importance of the arithmetic mean in the analysis of cost data.48
The main analysis used cases for which complete data were available at follow-up and missing data
imputation were not used. We used multiple imputation to test for the inﬂuence of missing cases in a
sensitivity analysis.
Cost-effectiveness planes were produced to show the probability that: brief intervention is more effective
and more costly than the control treatment; brief intervention is more effective and less costly than the
control treatment; brief intervention is less effective and less costly than the control treatment; and brief
intervention is less effective and more costly than the control treatment. The planes were constructed
using regression models of total cost and outcome by treatment group, from which 10,000 bootstrapped
resamples were run.
Knowledge of uncertainty around incremental cost-effectiveness is not sufﬁcient for decision-making,
which will depend on the how much society is willing to pay for improvements in outcomes.
Cost-effectiveness acceptability curves (CEACs) were constructed, which show the likelihood that
brief intervention is more cost-effective than the control treatment for different values a decision-maker is
willing to pay for improvements in outcome.49
METHODS
12
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Chapter 4 Results
Recruitment and randomisation
Study recruitment commenced in August 2010. Between August 2010 and May 2012, 1640 people were
assessed for participation in the study. Recruitment stopped at this point as the revised target sample size
had been exceeded and a decision was made to stop recruitment in a trial management meeting. Of the
1640 people assessed, 802 (49%) were eligible and willing to provide consent and were randomised. The
reasons for non-participation were not willing to provide consent (n = 447, 53%), not drinking alcohol
excessively (n = 369, 44%) and insufﬁcient spoken English to complete the baseline assessment (n = 22,
3%) (Figure 1). Of the 802 people who took part in the study, 400 were allocated to the control group
and 402 were allocated to brief intervention.
Characteristics of the study sample
Sociodemographic and clinical characteristics of study participants at baseline are presented in Table 2.
Participants were recruited from three hospital sites. Just under two-thirds of the participants were
recruited from the West London Centre for Sexual Health based at Charing Cross Hospital, London, UK
(hospital site 1; n = 495, 61.7%); one-quarter were recruited from the John Hunter Clinic for Sexual Health
based at Chelsea and Westminster Hospital, London, UK (hospital site 2; n = 206, 25.7%); and the others
were recruited from the Jefferiss wing based at St Mary’s Hospital, London, UK (hospital site 3; n = 101,
12.6%). Participants ranged in age from 19 to 55 years (median age 27 years) and just over half (54%)
were female. Most participants presented to the service either because they were experiencing
genitourinary symptoms or for a health check.
The results of the baseline assessment are presented in Tables 2 and 3 and show that, while the groups
were generally well balanced, in the intervention group there was a lower proportion of heterosexual
participants and a lower proportion who reported having had unprotected sex in the previous 6 months.
Flow of participants through the trial
The Consolidated Standards of Reporting Trials (CONSORT) diagram (see Figure 1) summarises the ﬂow of
participants through the trial. A total of 592 participants (73.8%) were followed up at 6 months. Of the
210 (26.2%) participants who were not followed up at 6 months, 61 (29%) formally withdrew from the
study and the other 149 (71%) either could not be traced or did not take up repeated offers to be assessed.
Participants who did not complete the follow-up (n = 210, 26.2%) were on average younger (26.8 years
old vs. 28.1 years old, p = 0.009) and with higher-risk sexual behaviour (e.g. 45.2% did not use a condom
the ﬁrst time they had sex with their last partner vs. 34.9%, p = 0.008) than those who completed the
study. The attrition rate was not signiﬁcantly different between arms (24.7% in the control group vs.
27.6% in the intervention group, p = 0.36). There were no signiﬁcant differences in predictors of drop out
between arms.
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Masking of researchers conducting follow-up interviews
Researchers reported nine occasions when they became aware of a participants’ allocation status. All the
participants were from the brief intervention arm of the trial. This occurred on each occasion because the
participant told the researcher which arm of the trial they had been allocated to.
Uptake of allocated treatments
Four hundred and two participants were allocated to the brief intervention treatment, of whom 397 (99%)
received the treatment. The brief advice was delivered by a total of 79 clinicians, each seeing a median of
three trial participants [interquartile range (IQR) 1–6]. Three hundred and sixteen (79.9%) participants
received brief advice only from the clinician and 81 participants (20.1%) received brief advice and an
appointment with an AHW. Of those who had contact with the AHW, 33 (40.7%) met with the AHW for
their appointment and the remaining 48 (59.3%) received advice and support over the telephone. Table 4
details the alcohol consumption at follow-up by intervention for participants in the intervention arm.
Treatment ﬁdelity
Data from treatment proforma showed that, of the 402 randomised to brief intervention, 397 (99%)
received brief feedback that alcohol use at that level has the potential to harm health; 370 (92%) were
asked whether or not there was a link between alcohol use and attendance at the clinic; 397 (99%) were
given a leaﬂet on alcohol and health, of whom 372 (92.5%) took the leaﬂet; and 397 (99%) were offered
an appointment with an AHW.
Randomised
(n = 802)
Allocated to control 
(n = 400)
Allocated to intervention
(n = 402)
6 months’ follow-up
(n = 301)
6 months’ follow-up
(n = 291)
Drop-out (n = 111)
•  Withdrawn, n = 40
•  Lost to follow-up, n = 71
Drop-out (n = 99)
•  Withdrawn, n = 21
•  Lost to follow-up, n = 78
Assessed for eligibility
(n = 1640) 
Excluded (n = 838)
•  Insufficient English, n = 22
•  Did not consent, n = 447
•  Not excessive alcohol consumption, n = 369
Did not receive brief intervention (n = 5)
•  Clinician forgot, n = 3
•  Appointment terminated early, n = 1
•  Clinician decided not appropriate, n = 1
Brief advice only, n = 316 
Brief advice and appointment with an AHW, n = 81 
FIGURE 1 Study flow chart.
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TABLE 2 Sociodemographic and clinical characteristics of study participants at baseline
Variable Control (n = 399)a Intervention (n = 402) Total (n = 801)a
Clinic
Hospital site 1 247 (61.8%) 248 (61.7%) 495 (61.7%)
Hospital site 2 103 (25.8%) 103 (25.6%) 206 (25.7%)
Hospital site 3 50 (12.5%) 51 (12.7%) 101 (12.6%)
Gender
Male 183 (45.8%) 187 (46.5%) 370 (46.1%)
Female 217 (54.3%) 215 (53.5%) 432 (53.9%)
Age, years (median, IQR) 26.8 (23.4–30.4) 26.3 (23.7–30.4) 26.7 (23.6–30.4)
Ethnicity
White 309 (77.6%) 309 (77.1%) 618 (77.3%)
Black/mixed 52 (13.1%) 52 (13.0%) 104 (13.0%)
Asian/mixed 13 (3.3%) 16 (4.0%) 29 (3.6%)
Other 24 (6.0%) 24 (6.0%) 48 (6.0%)
Sexual orientation
Heterosexual 361 (90.5%) 325 (80.8%) 686 (85.6%)
Homosexual 34 (8.5%) 59 (14.7%) 93 (11.6%)
Bisexual 4 (1.0%) 18 (4.5%) 22 (2.7%)
Smoking status
No 228 (57.1%) 228 (56.7%) 456 (56.9%)
Yes 171 (42.9%) 174 (43.3%) 345 (43.1%)
Reason for presentation
Sexual health check only 166 (42.3%) 175 (44.2%) 341 (43.3%)
Symptoms 188 (48.0%) 185 (46.7%) 373 (47.3%)
Emergency contraception 6 (1.5%) 8 (2.0%) 14 (1.8%)
Further treatment/vaccination 20 (5.1%) 17 (4.3%) 37 (4.7%)
Other 12 (3.1%) 11 (2.8%) 23 (2.9%)
IQR, interquartile range.
a Baseline characteristics (except clinic, age and gender) were not recorded for one participant.
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TABLE 3 Alcohol and sexual behaviour questionnaire at baseline
Variable Control (n = 399) Intervention (n = 402) Total (n = 801)
Drinking 6+/8+ units in one session
Monthly 141 (35.3%) 153 (38.1%) 294 (36.7%)
Weekly 253 (63.4%) 242 (60.2%) 495 (61.8%)
Daily 5 (1.3%) 7 (1.7%) 12 (1.5%)
In the past 6 months
Number of sexual partners
1 145 (36.3%) 164 (40.8%) 309 (38.6%)
> 1 254 (63.7%) 238 (59.2%) 492 (61.4%)
Had unprotected sex?
No 45 (11.3%) 78 (19.4%) 123 (15.4%)
Yes 354 (88.7%) 324 (80.6%) 678 (84.6%)
Number of unprotected sexual partners (mean, SD) 1.7 (1.6) 1.4 (1.3) 1.6 (1.4)
Regretted sex?
No 255 (63.9%) 269 (66.9%) 524 (65.4%)
Yes 144 (36.1%) 133 (33.1%) 277 (34.6%)
Last partner
How long had known them before ﬁrst had sex?
Just met them 57 (14.3%) 38 (9.5%) 95 (11.9%)
A day 19 (4.8%) 13 (3.2%) 32 (4.0%)
A few days 27 (6.8%) 30 (7.5%) 57 (7.1%)
A week 46 (11.5%) 42 (10.4%) 88 (11.0%)
A month 131 (32.8%) 153 (38.1%) 284 (35.5%)
A year 119 (29.8%) 126 (31.3%) 245 (30.6%)
Used condom ﬁrst time had sex?
No 151 (37.8%) 150 (37.3%) 301 (37.6%)
Yes 248 (62.2%) 252 (62.7%) 500 (62.4%)
Used contraception with this person?
No 150 (37.6%) 144 (35.8%) 294 (36.7%)
Yes 234 (58.6%) 243 (60.4%) 477 (59.6%)
Do not know 15 (3.8%) 15 (3.7%) 30 (3.7%)
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Main and secondary outcomes
Primary and secondary outcomes at the 6-month follow-up are described in Table 5. In the intervention
arm, weekly alcohol consumption was 2.33 units lower and fewer participants than in the control arm
reported having unprotected sex.
Table 6 shows the effect of allocation to the intervention arm compared with the control treatment. At
6 months, participants allocated to brief intervention had a reduction in mean weekly alcohol consumption
(adjusted mean difference –2.33 units/week; 95% CI –4.69 to 0.03 units/week; p = 0.053). This difference
corresponds to a –0.14 standardised effect size (SD = 16.1). There was no evidence of a difference in the
proportions who had had unprotected sex in the past 3 months [adjusted odds ratio (OR) 0.89, 95% CI
0.63 to 1.25; p = 0.496]. For other secondary outcomes, only the average number of units drunk per
drinking day showed a statistically signiﬁcant result (difference –1.13 units/drinking day; 95% CI –1.96 to
–0.29 units/drinking day; p = 0.009), suggesting that during drinking days the intervention group drank
fewer units on average than the control group.
Sensitivity analyses
The results of the different sensitivity analyses models are reported in Appendix 5. For the primary
outcome, results were all consistent with there being a small difference in weekly alcohol consumption
between the treatment arms, which was close to statistical signiﬁcance. The bootstrap bias-corrected and
accelerated CIs for the mean difference was –4.55 to 0.31. None of the calculated CIs included a
difference between the treatment arms of ≥ 5 units. For the main secondary outcome, results were also
consistent between sensitivity analyses, giving an OR of around 0.90, except when the difference in
unprotected sex at baseline was not accounted for or ignored (OR = 0.78). None of the results were
statistically signiﬁcant at the 5% level.
Missing data
Baseline data were missing for only one participant and were imputed using mean imputation. Meanwhile,
data for 210 patients were missing at the ﬁnal follow-up owing to withdrawal and loss to follow-up: 99 in
the control group and 111 in the intervention group (see Figure 1). After multiple imputation of these
missing outcomes, the adjusted mean difference in the primary outcome was –2.43 (95% CI –4.73
to –0.13; p = 0.038) and the OR for the main secondary outcome was 0.89 (95% CI 0.63 to 1.25;
p = 0.494) (see Appendix 5).
TABLE 4 Alcohol consumption by intervention received
Trial intervention received
Baseline Follow-up (units of alcohol/week)
n (N = 402)
M-SASQ
baselinea n (N = 291) Mean Median
First
quartile
Third
quartile
None 5 (1%) 3 (60%) 2 14.2 14.2 4.4 23.9
Brief advice only 316 (79%) 195 (62%) 221 18.2 15.1 6.8 24.3
Brief advice and input from
AHW (face to face)
33 (8%) 22 (67%) 30 20.3 13.0 7.4 30.4
Brief advice and input from
AHW (over the telephone)
48 (12%) 29 (60%) 38 16.0 11.8 4.1 25.4
a Number and proportion drinking more than 6 units for women or 8 units for men on one occasion weekly or daily at baseline.
DOI: 10.3310/hta18300 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 30
17
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Crawford et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
TABLE 5 Outcomes at follow-up by trial arm
Outcome Control (n = 301) Intervention (n = 291)
Primary
Weekly alcohol consumption (units)
Mean (SD) 20.3 (16.6) 18.1 (15.6)
Median (IQR) 15.7 (8.3–29.9) 14.1 (6.5–25.1)
Main secondary
Had unprotected sex?
No 123 (40.9%) 137 (47.1%)
Yes 178 (59.1%) 154 (52.9%)
Secondary: alcohol
Average units on drinking days
Mean (SD) 10.4 (5.8) 9.3 (5.3)
Median (IQR) 9.4 (6.5–13.4) 8.6 (5.6–11.4)
Proportion of days abstinent
Mean (SD) 70.7 (22.6) 70.9 (22.1)
Median (IQR) 75.6 (62.2–87.8) 75.6 (58.9–87.8)
Drinking excessively according to M-SASQ?
No 55 (18.3%) 70 (24.1%)
Yes 246 (81.7%) 221 (75.9%)
Secondary: sexual behaviour
Number of sexual partners
Mean (SD) 1.9 (2.9) 1.6 (2.2)
Median (IQR) 1 (1–2) 1 (1–2)
Number of unprotected partners
Mean (SD) 0.8 (1.1) 0.6 (0.8)
Median (IQR) 1 (0–1) 1 (0–1)
Occurrence of regretted sex?
No 273 (90.7%) 263 (90.4%)
Yes 28 (9.3%) 28 (9.6%)
Unprotected sex after drinking?
No 165 (54.8%) 183 (2.9%)
Yes 136 (45.2%) 108 (37.1%)
Unprotected sex after feeling drunk?
No 245 (81.4%) 234 (80.4%)
Yes 56 (18.6%) 57 (19.6%)
Had sex when just met (last partner)?
No 280 (93.0%) 275 (94.5%)
Yes 21 (7.0%) 16 (5.5%)
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The results of a sensitivity analyses based on the assumption that outcome data were missing non at
random are reported for the primary outcome and main secondary outcome in Appendix 6. The primary
outcome result could differ if there is an important difference in the response pattern between the arms;
however, in the more plausible scenarios the mean difference remained small (between –4 and 0 units per
week). In the most extreme scenario missing control group participants were assumed to drink, on
average, 15 units per week more than control group participants who completed follow-up, whereas
intervention group non-completers were assumed to drink on average 5 units per week less than their
completer equivalents. Under this scenario, the difference in mean alcohol consumption between the
groups could be as high as –7.17 units per week. For the main secondary outcomes, all scenarios gave a
non-signiﬁcant difference between arms, with an OR likely to remain between 0.8 and 1.0.
TABLE 5 Outcomes at follow-up by trial arm (continued )
Outcome Control (n = 301) Intervention (n = 291)
Unplanned pregnancy (n = 316)?
No 160 (98.8%) 152 (98.7%)
Yes 2 (1.2%) 2 (1.3%)
New STI diagnosis?
No 287 (95.3%) 283 (97.3%)
Yes 14 (4.7%) 8 (2.7%)
TABLE 6 Impact of brief intervention on all the main study outcomes
Outcome
Comparison
Regression/test Coefﬁcient 95% CI p-value
Primary outcome
Weekly alcohol consumption Linear β = –2.33 –4.69 to 0.03 0.053
Main secondary
Had unprotected sex Logistic OR = 0.89 0.63 to 1.25 0.496
Secondary outcomes
Average units on drinking days Linear β = –1.13 –1.96 to –0.29 0.009
Proportion of days abstinent Linear β = 0.20 –3.03 to 3.44 0.902
Drinking excessively (M-SASQ) Logistic OR = 0.70 0.46 to 1.05 0.087
Number of sexual partners Negative binomial β = –0.13 –0.29 to 0.02 0.097
Number of unprotected partners Poisson β = –0.11 –0.31 to 0.08 0.252
Occurrence of regretted sex Logistic OR = 1.05 –1.84 to 0.60 0.871
Unprotected sex after drinking Logistic OR = 0.79 –1.11 to 0.56 0.174
Unprotected sex after feeling drunk Logistic OR = 1.15 –1.75 to 0.76 0.504
Had sex when just met Logistic OR = 0.80 –1.65 to 0.39 0.549
Unplanned pregnancy (n = 316) Fisher’s exact test OR = 1.05 – 1.000
New STI diagnosis Fisher’s exact test OR = 0.58 – 0.279
Regression adjusted for age, gender, clinic and corresponding variable at baseline (M-SASQ, more than one sexual partner,
number of unprotected partners, regretted sex, unprotected sex or had sex when just met).
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Subgroup analysis
Differences in primary and main secondary outcomes by subgroups are reported in Figure 2 and Table 7.
There was a possible trend for the intervention to be more effective in reducing unprotected sex with
increased age, although the result was not statistically signiﬁcant and has to be interpreted in
consideration of the multiple comparisons and low power of the interaction test.
Overall
Gender
Age (years)
Sexual partners last 6 months
Sexual orientation
Male
Female
< 25
25–34
35+
1
>1
Heterosexual
Homosexual/bisexual
     Favours intervention      Favours control
–10 –5 0 5 10
Mean difference
No effect
95% CI
Overall effect
(a)
Overall
Gender
Age (years)
Sexual partners last 6 months
Sexual orientation
Male
Female
< 25
25–34
35+
1
>1
Heterosexual
Homosexual/bisexual
     Favours intervention      Favours control
0.25 0.5 1 2 4
Odds ratio
No effect
95% CI
Overall effect
(b)
FIGURE 2 Forest plot of difference in primary and main secondary outcome by subgroups. (a) Difference in weekly
alcohol consumption; and (b) OR of unprotected sexual relations.
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Economic evaluation
Service use
Service use over the 6-month follow-up is detailed in Table 8 and shows how use of health and
community services was broadly similar in the control and brief intervention groups.
Cost
Mean cost of services per participant over 6-month follow-up is detailed in Table 9. There was no
difference in service cost between those randomised to the control condition (£310.87) and those
randomised to brief intervention (£319.28, p = 0.879). The cost of the brief intervention was on average
£12.57 per participant, which represented around 4% of total service costs. The average cost per
participant for outpatient STI appointments was £23.97 in the control group and £25.55 in the brief
intervention group. Imputation of missing data did not alter the direction or difference in total costs
[control (n = 400) £311.13; brief intervention (n = 402) £319.64, p = 0.835].
Economic outcomes
Quality-adjusted life-years are detailed in Table 10. Mean QALYs were similar between groups at 6-month
follow-up and there were no statistically signiﬁcant differences in EQ-5D scores or QALYs. Units of alcohol
per week for those with complete economic data were 20 in the control group and 18 in the brief
intervention group.
Cost-effectiveness
There were no signiﬁcant between-group differences in costs or outcomes. QALYs over follow-up were
0.007 lower in the brief intervention group, and costs were £8.41 higher, which results in a negative
incremental cost-effectiveness ratio (ICER) of –£1200.00 per QALY, suggesting that the control dominates
TABLE 7 Difference in outcomes, and signiﬁcance of interaction terms for each subgroup analysis
Subgroup n
Adjusted mean
difference (95% CI)
p-value
interaction
Adjusted OR
(95% CI)
p-value
interaction
Gender
Male 276 –3.86 (–7.59 to –0.12) 0.15 0.92 (0.55 to 1.53) 0.99
Female 316 –0.59 (–3.35 to 2.17) 0.89 (0.56 to 1.42)
Age (years): categories
< 25 212 –0.61 (–4.69 to 3.48) 0.19 1.09 (0.60 to 1.97) 0.35
25–34 308 –4.04 (–7.11 to –0.98) 0.88 (0.55 to 1.42)
≥ 35 72 1.99 (–4.92 to 8.89) 0.47 (0.16 to 1.38)
Age: linear 592 – 0.92a – 0.083a
Number of partners
One 233 –3.02 (–6.16 to 0.13) 0.63 0.94 (0.54 to 1.64) 0.78
More than one 358 –1.68 (–4.83 to 1.48) 0.85 (0.54 to 1.32)
Sexual orientation
Heterosexual 500 –2.04 (–4.51 to 0.43) 0.74 0.89 (0.62 to 1.28) 0.55
Other 91 –1.08 (–7.74 to 5.59) 1.60 (0.55 to 4.71)
a In the direction of greater intervention effect with increasing age.
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TABLE 8 Use of services over 6 months’ follow-up, mean per participant
Service
Control (n = 301) Brief intervention (n = 290)
% using service Mean SD % using service Mean SD
Inpatient (nights) 5 0.11 0.69 4 0.11 0.68
Outpatient (appointments) 41 0.93 1.83 43 0.87 1.38
Accident and emergency (attendances) 19 0.21 0.46 11 0.12 0.40
GP surgery (contacts) 49 1.05 1.73 55 1.17 1.99
GP telephone (contacts) 5 0.02 0.13 0 0.00 0.00
Practice nurse (contacts) 18 0.20 0.45 16 0.21 0.59
Health visitor/district nurse (contacts) 0 0.00 0.00 1 0.00 0.06
Physiotherapist (contacts) 4 0.26 2.83 4 0.11 0.65
Counsellor (contacts) 4 0.15 0.95 2 0.18 1.38
Chiropody/podiatry (contacts) 0 0.00 0.00 1 0.01 0.13
Advice centre (contacts) 1 0.02 0.20 1 0.04 0.49
Complementary medicine (number) 2 0.16 1.56 1 0.09 0.87
NHS Direct (calls) 1 0.01 0.12 1 0.00 0.06
Community sexual health clinic (contacts) 1 0.01 0.10 1 0.01 0.14
GP, general practitioner.
TABLE 9 Mean cost per participant (£) over 6 months’ follow-up
Service
Control (n = 301)
Brief intervention
(n = 290)
Difference 95% CI p-valueMean (£) SD (£) Mean (£) SD (£)
Brief alcohol intervention 0.00 0.00 12.57 6.59
Hospital STI outpatient
appointments
23.97 55.16 25.55 51.75
All other hospital services 152.35 446.70 133.13 359.05
Community health and
social services
74.59 256.89 60.73 165.01
Medication 59.96 235.87 87.30 404.71
Total cost 310.87 681.12 319.28 662.69 8.41 –98 to 1154 0.879
TABLE 10 QALYs over 6 months’ follow-up, mean per participant
Outcome measure
Control (n = 301)
Brief intervention
(n = 290)
Difference
Bootstrapped,
95% CIMean SD Mean SD
EQ-5D score baseline 0.903 0.153 0.889 0.165
EQ-5D score follow-up 0.922 0.144 0.910 0.150
QALYs over follow-up (n = 589) 0.457 0.063 0.450 0.066 –0.007 –0.0174 to 0.003
Units of alcohol per week (n = 591) 20.256 16.553 18.110 15.630 –2.280 –4.672 to 0.117
RESULTS
22
NIHR Journals Library www.journalslibrary.nihr.ac.uk
the brief intervention. For the alcohol consumption outcome, 2 fewer units per week were consumed on
average in the brief intervention group and costs were £8.41 higher, resulting in an ICER of £4.20 per unit
reduction in weekly alcohol consumption. Given the lack of statistical signiﬁcance in these ICERs, attention
needs to be given to uncertainty represented in the scatterplots and CEACs presented below.
The bootstrapped replications for costs and QALYs are shown on a cost-effectiveness plane in Figure 3.
Most of the dots lie to the left of the x-axis (brief intervention associated with worse outcomes than
control) and above the y-axis (brief intervention associated with higher costs than control) suggesting that
the brief intervention is not cost-effective. The CEAC (Figure 4) conﬁrms this ﬁnding, for willingness-to-pay
values for a QALY up to £30,000 there is no more than a 42% probability that brief intervention is more
cost-effective than the control treatment.
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FIGURE 3 Cost-effectiveness plane for the comparison of the brief intervention and usual care, based on
10,000 bootstrapped cost–effect pairs, using QALYs.
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FIGURE 4 Cost-effectiveness acceptability curve showing probability that brief intervention is cost-effective
compared with usual care for different values of willingness to pay per QALY.
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The bootstrapped replications for costs and alcohol consumption are shown on a cost-effectiveness
plane in Figure 5. Most of the dots lie to the left of the x-axis (brief intervention associated with better
outcomes) and above the y-axis (brief intervention costs higher), suggesting that the brief intervention
could be cost-effective, depending on society’s willingness to pay for a unit reduction in weekly alcohol
consumption. The CEAC (Figure 6) summarises information on willingness to pay and cost-effectiveness.
If society places a value of zero on its willingness to pay for a unit reduction in alcohol consumption, then
the probability of brief intervention being more cost-effective than the control treatment is 44%. However,
if society is willing to pay up to £5 per unit reduction in alcohol consumption then the probability of
cost-effectiveness increases to over 50%.
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FIGURE 5 Cost-effectiveness plane for the comparison of the brief intervention and usual care, based on
10,000 bootstrapped cost–effect pairs using weekly alcohol consumption.
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FIGURE 6 Cost-effectiveness acceptability curve showing probability that brief intervention is cost-effective
compared with usual care for different values of willingness to pay per unit reduction in weekly alcohol consumption.
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Chapter 5 Discussion
Study ﬁndings
Data from this randomised trial of brief intervention for excessive alcohol use among people attending
sexual health clinics suggest that there is little, if any, difference in alcohol consumption between those
who are and are not offered this intervention. Follow-up data collected from 592 (74%) of the
802 participants at 6 months showed that those who were randomised to brief intervention were drinking
a mean of 2.3 units (18.4 g) of alcohol less per week than those randomised to the control group.
Interpreting results of trials with borderline signiﬁcance is not straightforward. In keeping with the
recommendations of Hackshaw and Kirkwood,50 we base this conclusion on the clinical signiﬁcance of the
changes we found rather than on the probability of the difference being the result of chance. Although
a statistically signiﬁcant difference in the number of units of alcohol per drinking day was observed, the
scale of the difference (1.1 units/8.8 g) is unlikely to be clinically important. Signiﬁcant differences in sexual
health outcomes were not found between the groups, though we cannot rule out the possibility that brief
intervention could be associated with small, but clinically important, changes in sexual health outcomes. At
less than £13.00 per participant, brief intervention was inexpensive. When other costs and outcomes were
taken into account we found little evidence that the intervention would provide a cost-effective use of
resources. The results of the cost-effectiveness analysis suggest that if a service were to be willing to pay
£5.00 for a weekly unit reduction in alcohol consumption, the brief intervention would have a > 50%
chance of being cost-effective. However, the relevance of this interpretation is difﬁcult since we know that
a weekly reduction in alcohol consumption is not a clinically meaningful change.
Strengths and weaknesses of the study
The rate of recruitment to the study was higher than we initially anticipated. With the approval of the
independent Trial Steering Group, Data Monitoring Committee and Research Ethics Committee and
the support of the study funder we increased the planned sample size to increase the statistical power
that we had to examine the impact of the intervention on our secondary outcomes. The sample of over
800 participants was large enough to detect clinically important changes in alcohol consumption and
moderate to large changes in sexual behaviour. The rate of follow-up we achieved was also higher than
we had planned, with 74% of all participants followed up at 6 months. Two other notable strengths of
the study relate to the recruitment and assessment process we used and the type of intervention received
by those in the active arm of the trial.
Recruitment to the study involved asking potential participants if they would be willing to take part in a
study of ‘sexual health and lifestyle’. Written and verbal information given to participants made no explicit
reference to alcohol use. When assessing whether or not potential participants were eligible to take part,
we used a single question on alcohol use which was embedded in a series of other questions about
smoking, exercise and diet. By using this approach we were able to reduce exposure to prompts about
alcohol use which could have encouraged those in the control arm of the trial to reﬂect on their use of
alcohol and consider reducing this. In doing so, we believe that we have replicated normal clinical practice
in sexual health clinics where information about alcohol is not normally collected. Previous trials of brief
intervention for alcohol misuse have been criticised for underestimating the effects of screening and
intervention by exposing control participants to more detailed questions about alcohol, which may in
themselves lead to reductions in alcohol consumption.51
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We based our intervention on a form of brief advice which is acceptable to staff working in busy clinical
settings and can be delivered in under a minute.52 Evidence for the acceptability of the approach was
found by data from the active arm of the trial showing that almost 99% of people received brief advice.
This approach does not require clinicians to deliver anything other than very simple advice to accompany
a leaﬂet on alcohol and health and the offer of more intensive advice and support for those who want it.
By testing an approach to intervention which was delivered by front-line clinicians rather than specially
trained staff, we believe that we took a pragmatic approach to testing an approach to helping people
who consume excessive alcohol which had the potential to be delivered widely as part of routine
clinical practice.
The study has a number of limitations which should be considered when interpreting the ﬁndings.
Although we recruited more participants than we planned, these were all from three sexual health clinics
in inner and central London. Although this area covers over 500,000 residents from a range of different
socioeconomic backgrounds, we do not know if our results would have been the same had participants
been recruited from other parts of the country.
In our effort to maximise recruitment in this busy clinical setting and minimise exposure to prompts about
alcohol use for control participants we used a very short baseline assessment which did not involve
collecting detailed information about alcohol use or service utilisation. This meant that we had limited data
to compare the characteristics of those in the two arms of the trial or information that could be used to
impute follow-up data on those from whom this was not obtained.
Although we used validated outcome measures that have been widely used in previous trials, these were
based on the self-reporting by study participants. We do not know the extent to which they provide an
accurate measure of actual behaviour. In addition, the economic evaluation used the EQ-5D to measure
quality of life, which has been shown to be insensitive to changes in levels of alcohol consumption
amongst hazardous drinkers.
At 74%, the rate of follow-up we achieved is similar to that of other trials of brief intervention for alcohol
misuse in secondary care settings.16,21 This remains an important level of attrition, and the intervention
effect observed in the completers could be a biased estimate of the effect in all participants, especially if
the intervention had a different effect in the non-responders, or if the intervention affected the chance of
response. However, the response rate was not highly different between the arms, and we perform
different sensitivity analyses to see how missing data could have affected the results. Although the
intervention effect estimate could be affected by the missing data, it appeared unlikely that the overall
conclusions of the trial would change.
Only a minority of those in the active arm of the trial received brief intervention from an appointment with
the AHW. This level of uptake of brief intervention is far higher than in a pilot study we conducted.9 We
believe that one of the reasons for this was that AHWs offered telephone-based intervention that did not
require participants to come back to the clinic.
Comparison with results of other studies
Very little research has been conducted to examine the impact of intervention for excessive alcohol use
among people attending sexual health services. Lane and colleagues compared the effects of brief
intervention for risky drinking delivered by a trained nurse in a sexual health clinic in Sydney, Australia,
among 184 people.21 They found a small, non-statistically signiﬁcant difference in the proportion of people
drinking harmfully among those who did and did not receive a brief intervention. Three months after
randomisation, 46% of those in the active arm of the trial and 39% in the control arm were drinking
excessively according to AUDIT-C (a three-item quantity frequency measure of alcohol consumption
derived from the 10-item Alcohol Use identiﬁcation test). These small differences in levels of alcohol
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consumption between treatment arms are of the same order of magnitude as the differences we found
in this study. We are aware of two other trials of brief intervention for alcohol among people who
attend sexual health clinics and are drinking above recommended limits, but neither has so far published
their ﬁndings.
In contrast, a large number of studies have been conducted across a range of other health-care settings
including primary care, emergency departments and specialist clinics. Findings from these trials have
generally shown that brief intervention is associated with clinically important reductions in alcohol
consumption over a 6- to 12-month period. In a systematic review of 22 clinical trials, Kaner and
colleagues reported a standardised mean difference of 5 units of alcohol per week at 6 months among
those who received active compared with control treatment.53 Changes in alcohol consumption of this
magnitude also seem to be associated with reductions in all-cause mortality.
There is no agreement about what constitutes a clinically signiﬁcant reduction in alcohol consumption.
However, other clinical trials have been powered to detect differences of between 3.5 and 10 units of
alcohol per week.16,54 Other trials have been powered to detect clinically important differences in the
proportion of people drinking excessively; such trials have been powered to detect differences in
proportions in the region of 13%12,55,56 rather than the difference of 5.8% that we found in this study.
It is unclear why larger differences in alcohol consumption were not found between the active and control
arms of the SHEAR trial. Possible reasons for this include the level of alcohol misuse among people
attending sexual health clinics, the intervention that people received and readiness to change.
Level of alcohol misuse among study participants
Previous research has established high levels of alcohol consumption among people attending sexual
health clinics. As many as 70% of attendees are drinking above recommended levels.10 In our study, 68%
of the attendees who completed the baseline questionnaire were drinking excessively according to the
M-SASQ criteria. We did not collect detailed information about the level of alcohol consumed at baseline.
However, at follow-up, information on alcohol consumption over the previous 12 weeks revealed that
participants were drinking a median of 15 units of alcohol a week – well below recommended maximum
levels of weekly alcohol consumption. With a median of 10 units per drinking day, most study participants
were regularly exceeding recommended limits for drinks per day and over three-quarters were therefore
classiﬁed as ‘drinking excessively’ according to the M-SASQ criteria. However, overall levels of alcohol
consumption were far lower than that seen in other intervention studies conducted in primary and
secondary care, where study participants were reported to be drinking three or four times as much as
SHEAR participants.16,53 There is some evidence that brief intervention is less effective among people have
lower levels of alcohol consumption.53 By recruiting participants whose level of alcohol consumption may
not have been as high as that in emergency departments and other hospital settings the likelihood of
demonstrating clinically signiﬁcant reductions in alcohol consumption may have been reduced.
Treatment ﬁdelity
The intervention that we used in the SHEAR trial was designed to meet national recommendations for
brief alcohol intervention and was modelled on that used in a previous trial which demonstrated positive
effects. However, it could only have been effective if it was delivered in the intended manner. Data
collected from treatment proforma indicate that nearly all those allocated to the intervention received each
of the four components of brief advice that they should have been offered.
It has been argued that, in order to be effective, those delivering brief interventions need to have a
positive attitude to the information they provide.57 A survey of all clinicians who delivered the brief
intervention that we conducted parallel to the trial demonstrated that the majority believed that there was
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a link between alcohol use and sexual health, and that the intervention they were asked to deliver had
the potential to help improve sexual health. Available data therefore suggest that the intervention was
delivered in the manner intended and that the largely negative ﬁndings of the trial are not the result of the
way the intervention was delivered.
Readiness to change
The opportunity to help a person reduce his or her use of alcohol when presenting to services with
health problems that may be related to excessive alcohol use has been called a ‘teachable moment’.58
Emergency departments may provide an effective point at which to intervene because the link between
alcohol use and negative effects on health such as gastrointestinal problems, accidents, injuries and
deliberate self-harm are closely related at the points at which the intervention is provided. In specialist
settings, such as maxillofacial clinics, a patient may have a clear sense of a causal link between excessive
alcohol consumption and physical trauma.13 There is some evidence that people using sexual health clinics,
while acknowledging a link between alcohol use and sexual behaviour, do not view this as one in which
alcohol use leads to STIs or other negative health consequences. In semistructured interviews with
100 women attending sexual health and family planning clinics, Taylor and colleagues reported that
participants rarely believed that alcohol consumption had led them to engage in sexual behaviour which
they would not have engaged in had they not been drinking.59 Instead participants said that sexual
encounters tended to take place in environments where alcohol and/or drug use were likely to occur or
they used alcohol instrumentally to engage in desired sexual behaviours.
We are in the process of analysing qualitative data from study participants which may help us develop a
better understanding of why clinically important changes in alcohol consumption were not found in the
study. Data analysis is ongoing and a report will be completed in 2014, but our impression thus far is that
people attending sexual health clinics and drinking above recommended daily units of alcohol do not view
the amount they consume as excessive. Instead it is seen as a normal part of their social life and a means
of having fun. These observations are supported by a secondary analysis of data from brief advice
proformas showing that 19% think that their attendance in the clinic could be related to their use of
alcohol (compared with over 69% of those in our previous study in an emergency department). Although
people attending sexual health clinics may want to achieve better sexual health, attempts to reduce
alcohol consumption are generally not seen by them as a necessary means of trying to achieve this aim.
Implications for services and future research
The results of this study do not support the routine use of screening and intervention for excessive alcohol
use among people attending sexual health clinics. Although assessment of alcohol use as part of wider
efforts to help some people with poor sexual health take steps aimed at reducing risky sexual behaviour
makes sense, universal use of screening and delivery of brief interventions does not appear to provide a
clinically effective or cost-effective use of available resources.
It is, however, possible that there are subgroups of people for whom brief alcohol intervention would be
helpful, for instance individuals with high levels of acquisition of new STIs in the context of high levels of
alcohol misuse and those seeking human immunodeﬁciency virus (HIV) post-exposure prophylaxis or
emergency contraception. Further research examining the impact of brief alcohol intervention among such
groups is warranted. We recommend that such studies set a higher threshold of excessive alcohol
consumption to determine entry into the study than the one we used (such as drinking above
recommended limits on a weekly, rather than a monthly, basis).
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We excluded people aged < 19 years from the trial. Levels of alcohol misuse may be higher among
teenagers attending sexual health clinics than among adults and future research should develop and test
the impact of age-appropriate methods to help young people reﬂect on, and reduce, their use of alcohol.
Data suggesting that population-based interventions that lead to lower levels of alcohol consumption also
have an impact on levels of new STIs are also important. There is currently a debate about public health
measures aimed at reducing alcohol consumption, such as setting a minimum price per unit alcohol. Such
changes may have an impact on rates of STIs and, if introduced, future studies should examine the impact
of these changes on sexual health outcomes.
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Chapter 6 Conclusions
Introduction of universal screening and brief intervention for excessive alcohol use among people whoattend sexual health clinics does not result in clinically important reductions in alcohol consumption or
provide a cost-effective use of resources and should not be introduced in routine clinical practice.
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Appendix 1 Patient and public involvement
Members of the British Youth Council and advisers from Brook (the national young people’s sexualhealth charity) were involved at several stages of the study. Prior to the start of data collection, they
were asked for suggestions about the design and content of information sheets and study questionnaires
which resulted in changes to these documents.
Towards the end of the study these advisers commented on emerging ﬁndings and their feedback helped
us develop the discussion and conclusions of the study.
These advisers also helped us prepare a one-page summary of the results of the study which has been sent
to all participants who requested feedback on the results of the study. Copies of this leaﬂet will also be
distributed to patients at each of the clinics that took part in the study.
Finally, a member of the trial steering group was selected on the basis of their having experience of using
health-care services.
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Appendix 2 Proforma for clinicians delivering
brief advice

SHEAR  
Sexual health and lifestyle advice  
 
 
________________________________________________ has been allocated to brief advice for alcohol misuse.  
 
Please provide the patient with the four components of brief advice listed below and tick the box to indicate that
each component was delivered. 
 
 
BRIEF ADVICE ONLY TAKES A MINUTE! 
 
                                                                       Please tick  
                                                                       if delivered  
 
1. Brief feedback on level of alcohol use and its potential to affect health 
  ‘From the information that you gave our researcher it seems                                    
that your use of alcohol could be harmful to your health’ 
          (Eight units per drinking session for a man, six for a woman) 
 
 
2. Making a link                                                                                                      YES    
      ‘Do you feel your attendance here could be related to your use                               
      of alcohol?’                                                                                                 NO           
  
 
 
3. Given a copy of the information leaflet: ‘’Think about drink” 
       ‘I would like to give you a leaflet which has information about alcohol                       
   and health’  
 
 
4. Offered an appointment with the Alcohol Nurse Specialist and provide                             
appointment card    
     ‘I would like to arrange for you to meet our Alcohol Nurse Specialist,  
  they would be able to see you at  <	
>    
                in this clinic’ 
 
 
 
 
 
 
 
 
 PLEASE PRINT YOUR NAME HERE 
 
 
 
 
 
THANK YOU FOR YOUR HELP WITH THE STUDY 
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Appendix 3 Proforma for alcohol health workers
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Appendix 4 Results of sensitivity analyses
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Missing not-at-random results
Colour code, likeliness of scenario:
Colour code, likeliness of scenario:
TABLE 12 Mean difference (95% CI) in weekly alcohol consumption for different missing non-at-random scenarios
MNAR delta
control group
MNAR delta intervention group (95% CI)
–5 0 8 15
–5 –2.24 (–4.53 to 0.06) –0.85 (–3.14 to 1.44) 1.36 (–0.96 to 3.67) 3.29 (0.91 to 5.67)
0 –3.47 (–5.76 to –1.18) –2.09 (–4.37 to 0.19) 0.12 (–2.18 to 2.43) 2.06 (–0.31 to 4.43)
8 –5.44 (–7.76 to –3.13) –4.06 (–6.37 to –1.76) –1.85 (–4.18 to 0.48) 0.08 (–2.31 to 2.48)
15 –7.17 (–9.55 to –4.80) –5.79 (–8.16 to –3.42) –3.58 (5.97 to –1.19) –1.64 (–4.10 to 0.81)
MNAR, missing non at random.
Deltas represent the assumed mean difference in weekly alcohol consumption between the participants who did not
complete follow-up compared with those who did (pattern-mixture approach). The likeliness of the scenarios is based on
assuming that non-responders are more likely to drink slightly more than responders (probably between 0 and 8 units more
per week), and that delta is more likely to be similar in both arms. Results are based on linear regression adjusted for age,
sex, clinic and baseline M-SASQ.
Likely
Very unlikely
TABLE 13 Odds ratio (95% CI) for unprotected sex in the last three months for different missing non-at-random
scenarios
Rate in non-responders: controla
Rate in non-responders: interventiona (95% CI)
52.9% 62.8% 73.7%
59.1% 0.89 (0.63 to 1.25) 0.99 (0.70 to 1.40) 1.12 (0.80 to 1.58)
68.4% 0.81 (0.57 to 1.14) 0.90 (0.64 to 1.27) 1.02 (0.72 to 1.43)
78.3% 0.73 (0.52 to 1.03) 0.81 (0.58 to 1.14) 0.92 (0.65 to 1.29)
a Rates of unprotected sex assumed in those who did not complete the follow-up. Corresponding to an informative
missingness odds ratio (IMOR) of 1.0, 1.5 and 2.5.
Likeliness of scenarios is based on the assumptions that non-responders were more likely to have unprotected sex (IMOR
around 1.5), and that the IMOR is more likely to be similar in both arms. Results based on logistic regression adjusted for
age, sex, clinic and baseline unprotected sex.
Likely
Very unlikely
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